Literature DB >> 7800106

Baseline measures and outcome predictions.

C Anderson1.   

Abstract

This paper reviews the methodological issues in the epidemiological study of the outcome from stroke. Data are presented from an unselected series of patients in whom the underlying stroke pathology is clearly defined. Although the natural history varies among the different pathological subtypes of stroke, simple clinical baseline measures of the severity of the neurological deficit (incontinence, loss of consciousness and severity of paresis) and premorbid level of disability and social functioning independently predict disability-free survival by 1 year, and may help direct management and research.

Entities:  

Mesh:

Year:  1994        PMID: 7800106     DOI: 10.1159/000110392

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  4 in total

1.  Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke.

Authors:  Natalia S Rost; Pedro Cougo; Svetlana Lorenzano; Hua Li; Lisa Cloonan; Mark Jrj Bouts; Arne Lauer; Mark R Etherton; Hasan H Karadeli; Patricia L Musolino; William A Copen; Ken Arai; Eng H Lo; Steve K Feske; Karen L Furie; Ona Wu
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-08       Impact factor: 6.200

Review 2.  Stroke care: how do we measure quality?

Authors:  Kieran Walsh; P H Gompertz; A G Rudd
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

3.  Effects of thrombolysis for acute stroke in patients with pre-existing disability.

Authors:  R Blaine Taylor Foell; Brian Silver; Jose G Merino; Edward H Wong; Bart M Demaerschalk; Fali Poncha; Arturo Tamayo; Vladimir Hachinski
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262

4.  Impact of pre-stroke dependency on outcome after endovascular therapy in acute ischemic stroke.

Authors:  Jan Gralla; Hakan Sarikaya; Lisa Oesch; Marcel Arnold; Corrado Bernasconi; Johannes Kaesmacher; Urs Fischer; Pascal J Mosimann; Simon Jung; Thomas Meinel; Martina Goeldlin; Mirjam Heldner; Bastian Volbers
Journal:  J Neurol       Date:  2020-08-31       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.